None listed
Conditions
Interventions
Group 1 Type of group
Five nights of intravaginal suppositories of 37.5 mg of metronidazole.
Group name:Group 3 Type of group
Five nights of Intravaginal suppositories of 750 mg of metronidazole plus 200 mg of Miconazole Nitrate
Sponsors
UNIVERSIDAD PERUANA CAYETANO HEREDIA,
Eligibility
Inclusion criteria
Inclusion criteria: • Women between 18-40 years of age. • Abnormal vaginal discharge or bad-odor. • Quick positive test (QuickVue Advance). • Ability to provide informed consent.
Exclusion criteria
Exclusion criteria: • Women who report diabetes or immunosuppression. • Women who report symptoms of pregnancy, including loss of menstruation for a period greater than 7 days, or positive pregnancy test. • Women who have had a birth in the last 90 days. • Women who have had an abortion during the past 30 days. • Women who are menstruating or breastfeeding. • Oral or intravaginal medications for vaginal discharge during the last 2 weeks. • Inability to attend the follow-up visit one month after treatment ends. • Women with mucopurulent cervical discharge or vaginal bleeding. • Women with signs of pelvic inflammatory disease (eg, painful attachments or pain to cervical mobilization). • Women with ovarian and uterine masses on physical examination. • Women with severe abdominal pain. • Women who are taking cimetidine, phenytoin or coumadin.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome name:To compare the persistence rates of VB non-pregnant women between 18-40 years of age, randomly assigned to three different treatment schedules with intravaginal metronidazoi for five nights Measure:Persistence rates Timepoints:28 days | — |
Secondary
| Measure | Time frame |
|---|---|
| Outcome name:To compare the acceptability, adverse effects and adherence to treatment among these three treatment schemes. Measure:Acceptability, adverse effects and adherence to treatment Timepoints:During the treatment | — |
Contacts
Public ContactArmando Cotrina
UNIVERSIDAD PERUANA CAYETANO HEREDIA
Outcome results
None listed